54355-99-6

Basic information

• Product Name: 2-Propenal, 3-(3-furanyl)-, (2E)
• Synonyms: 2-Propenal, 3-(3-furanyl)-, (2E);(E)-3-(furan-3-yl)acrylaldehyde
• CAS NO: 54355-99-6
• Molecular Formula: C₇H₆O₂
• Molecular Weight: 122.12134
• EINECS: -0
• Mol File: 54355-99-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Propenal, 3-(3-furanyl)-, (2E)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propenal, 3-(3-furanyl)-, (2E)(54355-99-6)
• EPA Substance Registry System: 2-Propenal, 3-(3-furanyl)-, (2E)(54355-99-6)

Safety Data

• Hazardous Substances Data: 54355-99-6(Hazardous Substances Data)

Usage

General Description

2-Propenal, 3-(3-furanyl)-, (2E) is a chemical compound with the formula C7H6O2. It is also known as 2-furan-3-ylacrylaldehyde. 2-Propenal, 3-(3-furanyl)-, (2E) is an aldehyde with a furan ring attached to the third carbon of the acrylaldehyde chain. It is a colorless to yellow liquid with a pungent, fruity odor. 2-Propenal, 3-(3-furanyl)-, (2E) is used in the synthesis of various pharmaceuticals and as a flavoring agent in the food industry. It is also used in the production of perfumes and as a chemical intermediate in the manufacture of other organic compounds. Additionally, it has potential applications in the development of new materials and polymers.

Upstream product

• 54355-98-5 trans-3-(3'-Furanyl)prop-2-en-1-ol 
• 498-60-2 furan-3-carboxaldehyde 
• 75-07-0 acetaldehyde 
• 1151545-40-2 tris(ethoxyvinyl)borane 
• 121-44-8 triethylamine 
• 2136-75-6 (triphenylphosphoranylidene)acetaldehyde 
• 58963-70-5 trans-3-furan-3-yl-acrylic acid ethyl ester 

Relevant articles and documents

Easy construction of furo[2,3-f]isoindole core by the IMDAV reaction between 3-(furyl)allylamines and α,β-unsaturated acid anhydrides

The vinylogues of furfurylamines, easily available in two steps from furylacroleins (3-(furyl)allylamines), were studied in a tandem N-acylation/intramolecular [4+2] cycloaddition with maleic, pyrocinchonic, and citraconic anhydrides, as well as furylacry

Rare earth triflates/chlorotrimethylsilane-promoted one-pot synthesis of enals

Some heteroaromatic aldehydes were subjected to conditions promoting the rare earth triflates/chlorotrimethylsilane-promoted one-pot synthesis of enals. As a result, diverse α,β-unsaturated aldehydes were obtained in moderate yields.

A general method for the enantioselective synthesis of α-chiral heterocycles

The enantioselective formation of stereocenters proximal to unprotected heterocycles has been accomplished. Thus, vinyl boronic acids are added to heterocycle-appended enones via a modified-BINOL catalyst. Catalyst design was key to enable a general reaction. High yields and useful er's are observed for a host of common heteroaryls.

Simple one-pot conversion of aldehydes and ketones to enals

A simple and efficient method to convert aldehydes into α,β-unsaturated aldehydes with a two-carbon homologation is presented. Hydroboration of ethoxy acetylene with BH3·SMe 2 generates tris(ethoxyvinyl) borane. Transmetalation with

SULFONYLPYRAZOLE AND SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS

This invention concerns sulfonylpyrazoline carboxamidine derivatives as antagonists of 5-HT6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, binge eating disorders, panic attacks, akathisia, attention deficit hyperactivity disorder, attention deficit disorder, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, disorders associated with spinal trauma or head injury, hydrocephalus, functional bowel disorder, Irritable Bowel Syndrome, obesity and type-2 diabetes. The compounds have the general formula (1), wherein the symbols have the meanings given in the description.

1,4-DIHYDROPYRIDINE DERIVATIVES

A 1,4-dihydropyridine derivative having the formula (I): wherein, R1represents a substituted or unsubstituted phenyl or heterocyclic group, R2represents a C1to C5lower alkyl group, R3represents a substituted or unsubstituted C2to C8alkyl, alkenyl, alkynyl or substituted or unsubstituted cycloalkyl group, R4represents -A-R5, wherein A represents a C2to C8alkylene group or a substituted or unsubstituted C2to C8alkenylene group, and R5represents a substituted or unsubstituted pyridyl, pyridylcarbonyl or piperadinyl group and a drug for overcoming resistance to an anti-cancer drug or a drug increasing the effect of an anti-cancer drug containing as an effective ingredient the derivative or its pharmacologically acceptable salt or hydrate.

Total syntheses of strychnan- and aspidospermatan-type alkaloids. 2. Generation of 15-(3-furanyl) ABCE tetracyclic intermediates

The synthesis of Nb-benzyl-2-(dimethyl 2-malonyl)- and 2-(methyl 2- acetyl)tryptamines (21, 25) provides access to methyl 4-(3-furanyl)- 1,2,3,4,5,6-hexahydroazepino[4,5-b]indole-5-carboxylate (12) and methyl 3- benzyl-5-(3-furanyl)-2,3,3a,4,5,

FURAN AND PYRROLE CONTAINING LIPOXYGENASE INHIBITING COMPOUNDS

Substituted furan and pyrrole compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase.

Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase

Substituted furan and pyrrole compounds of formula (I) which are useful in inhibiting lipoxygenase enzymes, particuarly 5-lipoxygenase.